mTOR cascade activation distinguishes tubers from focal cortical dysplasia

Annals of Neurology

Volumn 56, Issue 4, 2004, Pages 478-487

  Baybis, Marianna ^a   Yu, Jia ^a   Lee, Allana ^a   Golden, Jeff A ^b   Weiner, Howard ^c   McKhann II, Guy ^d   Aronica, Eleonora ^e   Crino, Peter B ^a,f  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e UNIVERSITY OF AMSTERDAM   (Netherlands)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HAMARTIN; MESSENGER RNA; PROTEIN S6; PROTEIN TSC1; S6 KINASE; STAT3 PROTEIN; TARGET OF RAPAMYCIN KINASE; TUBERIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTIBODY LABELING; ARTICLE; BALLOON CELL; CELL ADHESION; CELL TYPE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICAL DYSPLASIA; FEMALE; GENE EXPRESSION; GENE MUTATION; GIANT CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; MALE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUBEROUS SCLEROSIS;

ADOLESCENT; ADULT; CELL COUNT; CEREBRAL CORTEX; CHILD; CHILD, PRESCHOOL; DNA-BINDING PROTEINS; EPILEPSY; EUKARYOTIC INITIATION FACTORS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFANT; INSULIN-LIKE GROWTH FACTOR II; MALE; MICRODISSECTION; PROTEIN KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBOSOMAL PROTEIN S6; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; RNA, MESSENGER; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA; TUBEROUS SCLEROSIS;

EID: 4844231148     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20211     Document Type: Article

References (36)

1. Taylor DC, Falconer MA, Bruton CJ, Corsellis JA. Focal dysplasia of the cerebral cortex in epilepsy. J Neurol Neurosurg Psych 1971;34:369-387.
2. Palmini A, Gambardella A, Andermann F, et al. Intrinsic epileptogenicity of human dysplastic cortex as suggested by corticography and surgical results. Ann Neurol 1995;37:476-487.
3. Whiting S, Duchowny M. Clinical spectrum of cortical dysplasia in childhood: diagnosis and treatment issues. Child Neurol 1999;14:759-771.
4. Senol U, Karaali K, Aktekin B, et al. Dizygotic twins with schizencephaly and focal cortical dysplasia. Am J Neuroradiol 2000; 21:1520-1521.
5. Brielimann RS, Jackson GD, Torn-Broers Y, Berkovic SF. Causes of epilepsies: insights from discordant monozygous twins. Ann Neurol 2001;49:45-52.
6. Crino PB, Miyata H, Vinters HVV. Neurodevelopmental disorders as a cause of seizures: neuropathologic, genetic, and mechanistic considerations. Brain Pathol 2002;12:212-233.
7. Mischel P, Nguyen LP, Vinters HV. Cerebral cortical dysplasia associated with pediatric epilepsy. Review of neuropathologic features and proposal for a grading system. J Neuropathol Exp Neurol 1995;54:137-153.
8. Barkovich AJ, Kuzniecky RI, Jackson GD, et al. Classification system for malformations of conical development: update 2001. Neurology 2001;57:2168-2178.
9. Yamanouchi H, Jay V, Rutka JT, et al. Evidence of abnormal differentiation in giant cells of tuberous sclerosis. Pediatr Neurol 1997;17:49-53.
10. Crino PB, Dichter MA, Trojanowski JQ, Eberwine J. Embryonic neuronal markers in tuberous sclerosis: single cell molecular pathology. Proc Nat Acad Sci USA 1996;93:14152-14157.
11. Duong T, De Rosa MJ, Poukens V, et al. Neuronal cytoskeletal abnormalities in human cerebral cortical dysplasia. Acta Neuropathol 1994;87:493-503.
12. Crino PB, Trojanowski JQ, Eberwine J. Internexin, MAP1B, and nestin in cortical dysplasia as markers of developmental maturity. Acta Neuropathol 1997;93:619-627.
13. Crino PB, Duhaime AC, Baltuch G, White R. Differential expression of glutamate and GABA-A receptor subunit mRNA in cortical dysplasia. Neurology 2001;56:906-913.
14. White R, Hua Y, Scheithauer B, et al. Selective alterations in glutamate and GABA receptor subunit mRNA expression in dysplastic neurons and giant cells of cortical tubers. Ann Neurol 2001;49:67-78.
15. Lee A, Maldonado M, Baybis MS, et al. Markers of cellular proliferation are expressed in cortical tubers. Ann Neurol 2003; 53:668-673.
16. Mizuguchi M, Yamanouchi H, Becker LE, et al. Doublecortin immunoreactivity in giant cells of tuberous sclerosis and focal cortical dysplasia. Acta Neuropathol 2002;104:418-424.
17. Maldonado M, Baybis M, Newman D, et al. Expression of ICAM-1, TNF-alpha, NFkappaB, and MAP kinase in tubers of the tuberous sclerosis complex. Neurobiol Dis 2003;14: 279-290.
18. Artazola P, Hino O, Kobayashi T, et al. Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling. Nat Cell Biol 2002;4:699-704.
19. El-Hashemite N, Zhang H, Henske EP, Kwiatkowski DJ. Mutation in TSC2 and activation of mammalian target of rapamycin signalling pathway in renal angiomyolipoma. Lancet 2003; 361:1348-1349.
20. Inoki K, Li Y, Zhu T, Wu J, Guan KL. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol 2002;4:648-657.
21. Kenerson HL, Aicher LD, True LD, Yeung RS. Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors. Cancer Res 2002;62: 5645-5650.
22. McManus EJ, Alessi DR. TSC1-TSC2: a complex tale of PKB-mediated S6K regulation. Nat Cell Biol 2002;4:214-216.
23. Tee AR, Fingar DC, Manning BD, et al. Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling. Proc Natl Acad Sci USA 2002;99: 13571-13576.
24. Oncla H, Crino PB, Zhang H, et al. Tsc2 null murine neuronal epithelial cells are a model for human tuber giant cells, and show activation of an mTOR pathway. Mol Cell Neurosci 2002;21:561-574.
25. Becker AJ, Urbach H, Scheffler B, et al. Focal cortical dysplasia of Taylor's balloon cell type: mutational analysis of the TSC1 gene indicates a pathogenic relationship to tuberous sclerosis. Ann Neurol 2002;52:29-37.
26. Roach ES, Gomez MR, Northrup H. Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. J Child Neurol 1998;13:624-628.
27. Kyin R, Hua Y, Baybis M, et al. Differential cellular expression of neurotrophins in cortical tubers of the tuberous sclerosis complex. AmJ Pathol 2001;159:1541-1554.
28. Kacharmina JE, Crino PB, Eberwine J. Preparation of cDNA from single cells and subcellular regions. Methods Enzymol 1999;303:3-18.
29. Dabora SL, Jozwiak S, Franz DN, et al. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet 2001;68:64-80.
30. Hua Y, Crino PB. Single cell lineage analysis in human focal cortical dysplasia. Cereb Cortex 2003;13:693-699.
31. Ginsberg SD, Crino PB, Hemby S, et al. Predominance of neuronal mRNAs in Alzheimer's disease senile plaques, Ann Neurol 1999;45:174-181.
32. O'Dell DM, Crino PB, Eberwine JH, McInrosh TK. Traumatic brain injury alters the molecular fingerprint of TUNEL-positive cortical neurons in vivo: a single cell analysis. J Neurosci 2000;20:4821-4828.
33. Ryzhova EV, Crino PB, Shawver L, et al. Simian immunodeficiency virus encephalitis: analysis of envelope sequences from individual brain multinucleated giant cells and tissue samples. Virology 2002;297:57-67.
34. Krieglstein K, Strelau J, Schober A, et al. TGF-beta and the regulation of neuron survival and death. J Physiol Paris 2002; 96:25-30.
35. Nguyen-Vu PA, Fackler I, Rust A, et al. Loss of tuberin, the tuberous-sclerosis-complex-2 gene product is associated with angiogenesis. J Cutan Pathol 2001;28:470-475.
36. Zhang H, Cicchetti G, Onda H, Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR. J Clin Invest 2003;112:1223-1233.